Showing 14 - 26 of 297
View by: Cover Page List Articles
-
Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan
published 31 May 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study
published 26 May 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
RWD-derived response in multiple myeloma
published 11 May 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders
published 01 May 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
published 06 Apr 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices
published 31 Mar 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Calprotectin as new potential clinical marker for multiple myeloma
published 16 Mar 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Evaluating the screening value of serum light chain ratio, β2 microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves
published 16 Feb 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
published 03 Jan 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs
published 08 Dec 2022
Loading metrics information...
Metrics unavailable. Please check back later.
-
Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma
published 01 Dec 2022
Loading metrics information...
Metrics unavailable. Please check back later.
-
Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy
published 31 Oct 2022
Loading metrics information...
Metrics unavailable. Please check back later.
-
LTβR overexpression promotes plasma cell accumulation
published 04 Aug 2022
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us